The effect of N-acetylcysteine on volume of uterine leiomyoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151228025732N44

Enrollment

Registered

2019-08-26

Start date

2018-02-07

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine. Injury of uterus

Interventions

Intervention 1: Intervention group: The drug is given to patients as an oral tablet of N-acetylcysteine (a 600 mg booster tablet made in Germany). Intervention 2: Control group: Placebo is given to pa

Eligibility

Sex/Gender

Female

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Women 20 to 50 years old Doubt to the leiomyoma in ultrasound, CT, MRI Leiomyoma size between 3 to 8 cm

Exclusion criteria

Exclusion criteria: History of cardiovascular disease Hormonal drug treatment

Design outcomes

Primary

Measure	Time frame
Size of leiomyoma. Timepoint: Before and after intervention. Method of measurement: Clinical and Para-clinical Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahrzad Aghaamoo

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026